Reporting to the Sr. Director of HEOR, the Director of HEOR, will be responsible for supporting global HEOR activities for Moderna’s broad portfolio, with a focus on vaccines.
This role will lead the development and execution of strategies for evidence generation, data analysis and dissemination, and engagement with thought leaders for Moderna’s vaccine pipeline. You will have the unique opportunity to help shape our development strategy, as opposed to working with inflexible development paths.
You will synthesize work across our scientific, clinical, and commercial groups into a coherent plan to develop vaccines that have a positive population impact across the broad healthcare system, as well as establish and communicate the value of the vaccines that Moderna develops to protect populations. This role will be focused on supporting mid- to late-stage vaccines as well as building a longer-term focus on additional products in our pipeline that support other therapeutic areas.
Here’s What You’ll Do:
- Contribute to the design, implementation and management of HEOR studies from concept through publication. HEOR studies may include retrospective database analysis, economic models, prospective research studies, patient-reported outcomes, and payer-focused tools.
- Lead the design of health economic models that can be used to explain the value of Moderna vaccines to various stakeholders.
- Collaborate with cross-functional product teams at every stage of development through launch. Partner with the broader vaccines commercial team in presentations to senior internal stakeholders, including our executive committee, and external stakeholders.
- Work closely with other functions including research and development strategy, epidemiology, regulatory, policy, and medical affairs on the development on programs that support broad access and value.
- Deliver best-practice project management oversight for all research and study-related activities.
- Understand the payer landscape and develop networks to engage with thought leaders who can provide input to guide Moderna programs.
- Represent Moderna at meetings where HEOR discussions and data are required.
- Be a key player in building HEOR capabilities within Moderna’s vaccines commercial organization, in partnership with newly formed teams that will blaze trails in new markets and grow Moderna at an accelerated pace.
- Comply with corporate policies and procedures as well as all applicable healthcare laws and regulations.
Here’s What You’ll Bring to the Table:
- Minimum of a Master’s degree in Public Health, Health Services Research, Economics, Epidemiology, Health Policy, or a related discipline. Doctorate preferred.
- 10+ years of progressive excellence with HEOR, with a successful track record of building and executing high-value-add research agendas.
- Experience in vaccines greatly preferred.
- Ability to collaborate with stakeholders from a range of key areas, including medical affairs, field team, marketing, communications, physician, trade and consumer channels, pricing and contracting, government payers.
- Extensive experience with outcomes-based strategies and tactics to meet scientific and commercial objectives and in conducting research studies that apply health economics, patient-reported outcomes, retrospective and prospective data analyses, epidemiology, and health services research.
- Best-in-class examples of leadership in HEOR that has created incremental value across the ecosystem to support market-leading access, defending value from pricing pressures and provided brand differentiation in the face of competition.
- Passion and ambition to excel in a critical role where developing strategies that explain and defend the value for a new scientific platform will be essential.
- Keen understanding of the drug development and regulatory approval process, and of health policy and health care system stakeholders (e.g., managed care, public sector payers, emerging models of care) for vaccines.
- Demonstrated past experience using real-world evidence and comparative effectiveness for health policy decision-making and a high degree of digital fluency are preferred.
- Excellent communication, presentation, collaboration and influencing skills across internal and external stakeholders.
Here’s What We’ll Bring to the Table:
- On-site subsidized cafeteria or catered lunches
- Company-provided iPhone
- Free parking, monthly subway pass or a subsidized commuter rail pass
- Free annual corporate membership to Bluebikes
- Highly competitive healthcare coverage including: medical offered through BCBS (HMO/PPO), dental, and vision offered through VSP
- Flexible Spending Accounts for medical expenses and dependent care expenses
- 16 weeks of 100% paid parental leave for all new parents
- 16 weeks 100% paid family caregiver leave
- 20 weeks 100% paid medical leave
- Eligible for “Moderna Month” (one month paid sabbatical after five years of service and eligible for additional one month paid sabbatical every 3 years thereafter)
- Adoption assistance and discounts to local childcare centers, as well as access to care.com
- 401k (traditional and Roth offered) with 50% match on first 6% deferred. Match is vested immediately
- A suite of Moderna paid insurance coverage, including: life insurance, short-term and long-term disability
- Voluntary legal assistance plan
- 15 days’ vacation and 7 sick days per year, in addition to a discretionary winter shut down and 11 company paid holidays (includes 2 floating holidays)
Candidates should be aware that Moderna currently maintains a policy requiring all US-based employees to be fully vaccinated against COVID-19. Newly hired employees must be vaccinated prior to their employment start date. Moderna is an equal opportunity employer and will provide a reasonable accommodation to those unable to be vaccinated where it is not an undue hardship to the company to do so as provided under federal, state, and local law.
In 10 years since its inception, Moderna has transformed from a science research-stage company advancing programs in the field of messenger RNA (mRNA), to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across six modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for both clinical and commercial production at scale and at unprecedented speed. Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both groundbreaking science and rapid scaling of manufacturing. Most recently, Moderna’s capabilities have come together to allow the authorized use of one of the earliest and most effective vaccines against the COVID-19 pandemic.
Moderna’s mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and auto-immune diseases. Moderna has been named a top biopharmaceutical employer by Science for the past six years. To learn more, visit www.modernatx.com.
Moderna is a smoke-free, alcohol-free and drug-free work environment.
Moderna is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person’s race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law. Moderna will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.